Separate and combined effects of nadolol and nifedipine on the cardiac response to exercise.
In a placebo controlled exercise protocol using healthy volunteers the effects of nadolol 80 mg and 160 mg orally and of nadolol 80 mg during treatment with nifedipine 20 mg 8 hourly were compared. Resting systolic and diastolic blood pressures were reduced by both nifedipine (p less than 0.05) and nadolol (p less than 0.01) acting alone. An unexpected finding was that nifedipine alone significantly inhibited exercise tachycardia (p less than 0.01) (8 to 12 h post dose). Predictably both doses of nadolol produced significant reduction in exercise tachycardia which was still apparent at 24 h. There was a linear relationship between log10 plasma nadolol concentration and reduction in exercise heart rate. The combined inhibitory effects of nifedipine and nadolol 80 mg on exercise heart rate showed partial additivity but did not summate. There was no pharmacokinetic interaction between the 2 drugs. The inhibition of exercise tachycardia by nifedipine, not previously documented, is consistent with an effect of the drug on the sinus node, as has been reported in in-vitro studies, and may contribute to the drugs efficacy in angina.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007700:Kinetics; D008297:Male; D009248:Nadolol; D009543:Nifedipine / Q000008:administration & dosage / Q000494:pharmacology*; D005082:Physical Exertion; D011412:Propanolamines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*
D011412:Propanolamines; D009248:Nadolol; D009543:Nifedipine